TSE:CTS Converge Technology Solutions (CTS) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free CTS Stock Alerts C$5.55 +0.01 (+0.18%) (As of 10:03 AM ET) Add Compare Share Share Today's RangeC$5.53▼C$5.6250-Day RangeC$4.46▼C$6.0052-Week RangeC$2.24▼C$6.06Volume49,237 shsAverage Volume466,851 shsMarket CapitalizationC$1.13 billionP/E RatioN/ADividend Yield0.72%Price TargetC$6.47 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades Get Converge Technology Solutions alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Converge Technology Solutions Stock (TSE:CTS)Converge Technology Solutions Corp. provides software-enabled IT and cloud solutions in the United States and Canada. Its solutions approach delivers advanced analytics, artificial intelligence, application modernization, cloud, cybersecurity, digital infrastructure, and digital workplace offerings to clients across various industries. The company also offers managed and talent services, and hardware and software products and solutions. Converge Technology Solutions Corp. was incorporated in 2016 and is headquartered in Toronto, Canada.Read More CTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTS Stock News HeadlinesMarch 11, 2024 | tmcnet.comConvergence, Automation, and Improved Customer Experiences: Key Trends Shaping 2024March 7, 2024 | markets.businessinsider.comCanadian Market Moderately Higher At Noon; Technology Stocks RallyApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!February 22, 2024 | finance.yahoo.comConverge Technology Solutions Recognized on CRN's 2024 MSP 500 ListFebruary 21, 2024 | wsj.comConverge Technology Solutions Corp.February 20, 2024 | morningstar.comConverge Technology Solutions CorpFebruary 13, 2024 | investing.comConverge Technology Solutions Corp (CTS)February 7, 2024 | finanznachrichten.deConverge Technology Solutions Corp.: Converge to Host Fourth Quarter and Fiscal Year 2023 Conference CallApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!February 7, 2024 | finance.yahoo.comConverge to Host Fourth Quarter and Fiscal Year 2023 Conference CallJanuary 29, 2024 | finance.yahoo.comConverge Provides Q4-2023 Cash Flow UpdateJanuary 22, 2024 | markets.businessinsider.comCanadian Market Pares Early Gains In Cautious TradeJanuary 12, 2024 | theglobeandmail.comClosing Bell: Converge Technology Solutions Corp flat on Friday (CTS)January 5, 2024 | finanznachrichten.deConverge Technology Solutions Corp.: Converge Announces Next "Coffee and Converge" Event Focused on Re-Imagining Application ModernizationJanuary 5, 2024 | finance.yahoo.comConverge Announces Next "Coffee and Converge" Event Focused on Re-Imagining Application ModernizationJanuary 3, 2024 | finanznachrichten.deConverge Technology Solutions Corp.: Converge Technology Solutions Announces UK and Germany Operations Achieve IBM Platinum Partner StatusJanuary 3, 2024 | finance.yahoo.comConverge Technology Solutions Announces UK and Germany Operations Achieve IBM Platinum Partner StatusDecember 5, 2023 | finance.yahoo.comWendy Bahr Joins Converge Technology Solutions Corp. Board of DirectorsNovember 21, 2023 | finance.yahoo.comStone Group, A Converge Company, Achieves Dell Technologies Titanium Partner StatusNovember 18, 2023 | finance.yahoo.comConverge Technology Solutions (TSE:CTS) shareholder returns have been fantastic, earning 416% in 5 yearsNovember 15, 2023 | msn.com2 Canadian Stocks for Beginners in November 2023October 26, 2023 | finance.yahoo.comConverge Technology Solutions Achieves CRN Triple Crown StatusOctober 23, 2023 | msn.comConverge Technology: Many Doubts About The Company, But It Is Very CheapOctober 20, 2023 | markets.businessinsider.comScotiabank Thinks Converge Technology Solutions Corp’s Stock is Going to RecoverOctober 20, 2023 | markets.businessinsider.comConverge Technology Solutions Corp (CTS) Gets a Buy Rating from Echelon Wealth PartnersOctober 19, 2023 | theglobeandmail.comClosing Bell: Converge Technology Solutions Corp flat on Thursday (CTS)October 19, 2023 | finanznachrichten.deConverge Technology Solutions Corp.: Q3-2023 Performance to be Stronger than ExpectedSee More Headlines Receive CTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Converge Technology Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Ex-Dividend for 3/26 Dividend3/11/2024Dividend Payable3/26/2024Today4/26/2024Next Earnings (Confirmed)5/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorComputer and Technology Industry Information Technology Services Sub-IndustryN/A Current SymbolTSE:CTS CUSIPN/A CIKN/A Webwww.convergetp.com Phone416 360 1495FaxN/AEmployees2,700Year FoundedN/APrice Target and Rating Average Stock Price TargetC$6.47 High Stock Price TargetC$9.00 Low Stock Price TargetC$5.00 Potential Upside/Downside+16.6%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E Ratio9.25 P/E Growth0.14Net IncomeC$-1,450,000.00 Net Margins-0.05% Pretax MarginN/A Return on Equity-1.03% Return on Assets1.32% Debt Debt-to-Equity Ratio71.05 Current Ratio1.04 Quick Ratio0.68 Sales & Book Value Annual SalesC$2.71 billion Price / Sales0.42 Cash FlowC$0.99 per share Price / Cash Flow5.63 Book ValueC$2.87 per share Price / Book1.93Miscellaneous Outstanding Shares203,410,000Free FloatN/AMarket CapC$1.13 billion OptionableNot Optionable Beta1.91 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Greg BerardChief Executive OfficerMs. Julianne BelagaChief Legal OfficerMr. Shaun Peter MaineGroup CEO & DirectorMr. John G. Teltsch Jr.Chief Revenue OfficerMr. Avjitpal KambojChief Financial OfficerMr. Cory ReidCOO & Chief Information OfficerMs. Karie TimionVice President of MarketingMs. Rhonda HanesVice President of People OperationsMr. David LuftigExecutive Vice President of Strategy & SolutionsMs. Emily MartinExecutive Vice President of Hybrid PlatformsMore ExecutivesKey CompetitorsSolium CapitalTSE:SUMSoftchoiceTSE:SFTCTELUS International (Cda)TSE:TIXTHammond Power SolutionsTSE:HPS.AEvertz TechnologiesTSE:ETView All CompetitorsInsidersCory ReidBought 2,315 shares on 3/22/2024Total: C$13,218.65 ($5.71/share)Toni RinowBought 500 shares on 3/22/2024Total: C$2,830.00 ($5.66/share)Greg BerardBought 8,775 shares on 3/20/2024Total: C$50,895.00 ($5.80/share)Cory ReidBought 2,135 shares on 12/4/2023Total: C$8,700.34 ($4.08/share)Avjit KambojBought 14,000 shares on 8/16/2023Total: C$35,560.00 ($2.54/share)View All Insider Transactions CTS Stock Analysis - Frequently Asked Questions Should I buy or sell Converge Technology Solutions stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Converge Technology Solutions in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTS shares. View CTS analyst ratings or view top-rated stocks. What is Converge Technology Solutions' stock price target for 2024? 7 analysts have issued twelve-month price objectives for Converge Technology Solutions' stock. Their CTS share price targets range from C$5.00 to C$9.00. On average, they predict the company's stock price to reach C$6.47 in the next year. This suggests a possible upside of 16.8% from the stock's current price. View analysts price targets for CTS or view top-rated stocks among Wall Street analysts. How have CTS shares performed in 2024? Converge Technology Solutions' stock was trading at C$4.14 at the beginning of 2024. Since then, CTS stock has increased by 33.8% and is now trading at C$5.54. View the best growth stocks for 2024 here. When is Converge Technology Solutions' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our CTS earnings forecast. How were Converge Technology Solutions' earnings last quarter? Converge Technology Solutions Corp. (TSE:CTS) released its quarterly earnings data on Wednesday, March, 6th. The company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.07. The business had revenue of $651.09 million for the quarter, compared to analysts' expectations of $712.08 million. Converge Technology Solutions had a negative net margin of 0.05% and a negative trailing twelve-month return on equity of 1.03%. How often does Converge Technology Solutions pay dividends? What is the dividend yield for Converge Technology Solutions? Converge Technology Solutions declared a quarterly dividend on Tuesday, March 5th. Investors of record on Tuesday, March 12th will be paid a dividend of 0.01 per share on Tuesday, March 26th. This represents a $0.04 annualized dividend and a dividend yield of 0.72%. The ex-dividend date of this dividend is Monday, March 11th. Read our dividend analysis for CTS. Is Converge Technology Solutions a good dividend stock? Converge Technology Solutions (TSE:CTS) pays an annual dividend of C$0.04 per share and currently has a dividend yield of 0.75%. Read our dividend analysis for CTS. How do I buy shares of Converge Technology Solutions? Shares of CTS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CTS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Converge Technology Solutions Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.